Pages that link to "Q38321799"
Jump to navigation
Jump to search
The following pages link to Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors (Q38321799):
Displaying 17 items.
- Chaperones in hepatitis C virus infection (Q26771251) (← links)
- Advances in experimental systems to study hepatitis C virus in vitro and in vivo (Q26851652) (← links)
- A new stochastic model for subgenomic hepatitis C virus replication considers drug resistant mutants (Q28541048) (← links)
- A CRISPR toolbox to study virus-host interactions (Q29994612) (← links)
- Genetic complementation of hepatitis C virus nonstructural protein functions associated with replication exhibits requirements that differ from those for virion assembly (Q35071597) (← links)
- Cyclophilin and NS5A inhibitors, but not other anti-hepatitis C virus (HCV) agents, preclude HCV-mediated formation of double-membrane-vesicle viral factories (Q35385005) (← links)
- Inhibitors of peptidyl proline isomerases as antivirals in hepatitis C and other viruses (Q35400246) (← links)
- Discovery of Novel Small Molecule Anti-HCV Agents via the CypA Inhibitory Mechanism Using O-Acylation-Directed Lead Optimization. (Q35656614) (← links)
- Cyclosporin A, but not tacrolimus, negatively affects the hepatic extraction fraction of hepatobiliary scintigraphy in liver transplant recipients (Q35675386) (← links)
- Novel therapies for hepatitis C - one pill fits all? (Q38117549) (← links)
- Cyclophilins as modulators of viral replication (Q38121470) (← links)
- An update on the management of hepatitis C virus-related arthritis (Q38242116) (← links)
- The role of immunophilins in viral infection (Q38274889) (← links)
- Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model (Q39191241) (← links)
- Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus (Q64058174) (← links)
- Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C (Q90669855) (← links)
- Hepatitis C virus exploits cyclophilin A to evade PKR (Q96354472) (← links)